BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Surgical Systems & Instruments, Inc. (SS&II) Release: Generic Scoring (Cutting) Balloon Patent Allowed


10/19/2005 5:09:37 PM

MANCHESTER, N.H., Jan. 6 /PRNewswire/ -- SS&II today announced the allowance of all claims of US patent publication No. 20020151924 broadly covering an angioplasty balloon with ridges mounted on its outer surface for treating occluded coronary and peripheral arteries. The balloon also incorporates a proprietary folding mechanism that shields the ridges and protects the arterial wall during delivery and withdrawal of the catheter. The ridges can be economically made from a 0.01 inch high triangular plastic extrusion with a sharpened edge. The ridges concentrate the balloon's dilating force and enable the opening of resistant lesions. This new design minimizes balloon stiffness, preserves the maneuverability of the device as it negotiates curved vessels, and reduces several risks, drawbacks, and length limitations associated with the use of metal ridges in the presently marketed devices.

"Gaining a generic patent position in this rapidly growing and lucrative field is important as this field becomes increasingly more competitive," said John Cvinar, founder of Seedling Enterprises and business advisor to SS&II. "Balloons covered by this patent have a large commercial potential because the design satisfies an important unmet clinical need in both the coronary and peripheral angioplasty markets. SS&II's technology provides new hope for patients with re-occluded stents, difficult to dilate fibrotic lesions or long lesions."

SS&II develops and licenses minimally-invasive devices for treating occlusive vascular disease. For additional information, visit SS&II on-line at http://www.surgicalsys.com/ or contact jcvinar@comcast.net.

SS&II

CONTACT: To reach SS&II: jcvinar@comcast.net



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES